CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 4-bromo-2-chlorophenol
Accession: CHEBI:38852
browse the term
Definition: A halophenol that is phenol in which the hydrogens at positions 2 and 4 have been replaced by chlorine and bromine, respectively.
Synonyms: related_synonym: 2-Chloro-4-bromophenol; Formula=C6H4BrClO; InChI=1S/C6H4BrClO/c7-4-1-2-6(9)5(8)3-4/h1-3,9H; InChIKey=VIBJPUXLAKVICD-UHFFFAOYSA-N; SMILES=Oc1ccc(Br)cc1Cl
xref: Beilstein:2042867; CAS:3964-56-5
xref_mesh: MESH:C075205
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
[CYP2B6 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol
CTD
PMID:23415833
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions
ISO
[CYP2C19 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol
CTD
PMID:23415833
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[CYP3A4 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol
CTD
PMID:23415833
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Ache
acetylcholinesterase
decreases activity
ISO EXP
profenofos results in decreased activity of ACHE protein profenofos metabolite results in decreased activity of ACHE protein; profenofos results in decreased activity of ACHE protein
CTD
PMID:16978018 PMID:21251949 PMID:30625376 PMID:33651127
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Alb
albumin
affects binding
ISO
profenofos binds to ALB protein
CTD
PMID:28407546
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Arid1a
AT-rich interaction domain 1A
decreases expression
EXP
profenofos results in decreased expression of ARID1A mRNA
CTD
PMID:17569032
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
G
Bche
butyrylcholinesterase
decreases activity
ISO
profenofos results in decreased activity of BCHE protein
CTD
PMID:9890196
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Casp3
caspase 3
multiple interactions
ISO
[cypermethrin co-treated with Chlorpyrifos co-treated with profenofos] results in increased cleavage of CASP3 protein
CTD
PMID:21987380
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
increases expression
EXP
profenofos results in increased expression of CAT mRNA
CTD
PMID:23495063
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Chrdl1
chordin-like 1
decreases expression
EXP
profenofos results in decreased expression of CHRDL1 mRNA
CTD
PMID:17569032
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
increases expression
EXP
profenofos results in increased expression of CYP11A1 mRNA
CTD
PMID:17569032
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
increases expression
EXP
profenofos results in increased expression of CYP17A1 mRNA
CTD
PMID:17569032
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases expression
EXP
profenofos results in decreased expression of CYP19A1 mRNA
CTD
PMID:18828448
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
ISO
profenofos results in decreased activity of CYP1A1 protein
CTD
PMID:20183062
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression decreases activity
ISO
profenofos results in increased expression of CYP1A2 mRNA profenofos results in decreased activity of CYP1A2 protein
CTD
PMID:20183062 PMID:22310298
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases expression increases metabolic processing multiple interactions decreases activity
ISO
profenofos results in increased expression of CYP2B6 mRNA CYP2B6 protein results in increased metabolism of profenofos [CYP2B6 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol profenofos results in decreased activity of CYP2B6 protein
CTD
PMID:22310298 PMID:23415833
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases expression
EXP
profenofos results in decreased expression of CYP2C11 mRNA; profenofos results in decreased expression of CYP2C11 protein
CTD
PMID:18828448
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases metabolic processing multiple interactions
ISO
CYP2C19 protein results in increased metabolism of profenofos [CYP2C19 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol
CTD
PMID:23415833
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions decreases activity
ISO
profenofos inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] profenofos results in decreased activity of CYP2E1 protein
CTD
PMID:22634058
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases expression multiple interactions increases activity increases metabolic processing increases expression
EXP ISO
profenofos results in decreased expression of CYP3A2 mRNA; profenofos results in decreased expression of CYP3A2 protein [CYP3A4 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol profenofos results in increased activity of CYP3A4 protein profenofos results in increased expression of CYP3A4 mRNA
CTD
PMID:18828448 PMID:22310298 PMID:23415833
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Faah
fatty acid amide hydrolase
decreases activity
ISO
profenofos results in decreased activity of FAAH protein
CTD
PMID:11350214
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
G
Gch1
GTP cyclohydrolase 1
decreases expression
EXP
profenofos results in decreased expression of GCH1 mRNA
CTD
PMID:17569032
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
decreases expression
EXP
profenofos results in decreased expression of GRIN2A mRNA
CTD
PMID:17569032
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Hao2
hydroxyacid oxidase 2
increases expression
EXP
profenofos results in increased expression of HAO2 mRNA
CTD
PMID:17569032
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Hp
haptoglobin
increases expression
EXP
profenofos results in increased expression of HP mRNA
CTD
PMID:17569032
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Lamc1
laminin subunit gamma 1
decreases expression
EXP
profenofos results in decreased expression of LAMC1 mRNA
CTD
PMID:17569032
NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
G
Mcam
melanoma cell adhesion molecule
decreases expression
EXP
profenofos results in decreased expression of MCAM mRNA
CTD
PMID:17569032
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Ms4a6a
membrane spanning 4-domains A6A
increases expression
EXP
profenofos results in increased expression of MS4A6A mRNA
CTD
PMID:17569032
NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
G
Myo1d
myosin ID
decreases expression
EXP
profenofos results in decreased expression of MYO1D mRNA
CTD
PMID:17569032
NCBI chr10:65,489,153...65,765,812
Ensembl chr10:65,489,154...65,766,349
G
Nceh1
neutral cholesterol ester hydrolase 1
decreases activity
ISO
profenofos results in decreased activity of NCEH1 protein
CTD
PMID:16978018
NCBI chr 2:110,074,985...110,135,592
Ensembl chr 2:110,074,957...110,135,588
G
Nell1
neural EGFL like 1
decreases expression
EXP
profenofos results in decreased expression of NELL1 mRNA
CTD
PMID:17569032
NCBI chr 1:99,709,305...100,573,872
Ensembl chr 1:99,709,793...100,573,860
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
increases expression
ISO
profenofos results in increased expression of NR1I3 mRNA
CTD
PMID:22310298
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrbf2
nuclear receptor binding factor 2
decreases expression
EXP
profenofos results in decreased expression of NRBF2 mRNA
CTD
PMID:17569032
NCBI chr20:21,308,555...21,326,881
Ensembl chr20:21,308,576...21,326,818
G
Pdzrn3
PDZ domain containing RING finger 3
increases expression
EXP
profenofos results in increased expression of PDZRN3 mRNA
CTD
PMID:17569032
NCBI chr 4:133,770,736...133,996,959
Ensembl chr 4:133,770,736...133,996,959
G
Rgs2
regulator of G-protein signaling 2
increases expression
EXP
profenofos results in increased expression of RGS2 mRNA
CTD
PMID:17569032
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rwdd2b
RWD domain containing 2B
increases expression
EXP
profenofos results in increased expression of RWDD2B mRNA
CTD
PMID:17569032
NCBI chr11:26,665,877...26,677,986
Ensembl chr11:26,665,877...26,674,603
G
Slc1a1
solute carrier family 1 member 1
decreases expression
EXP
profenofos results in decreased expression of SLC1A1 mRNA
CTD
PMID:17569032
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
G
Sod1
superoxide dismutase 1
increases expression
EXP
profenofos results in increased expression of SOD1 mRNA
CTD
PMID:23495063
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Star
steroidogenic acute regulatory protein
increases expression
EXP
profenofos results in increased expression of STAR mRNA
CTD
PMID:17569032
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all